Sara presented this analysis at the AMCP Annual Meeting 2026, helping bring real-world insights into conversations shaping the future of managed care, and were proud to share it as part of our Ventegra Insights series
On the Bolt Pharmacy blog today, we explore whether you can safely combine Wegovy, a revolutionary weight loss treatment from the GLP-1 drug class, and Sertraline, a commonly prescribed antidepressant
Retatrutide adds GIP and glucagon receptor activity, and the glucagon arm drives the hepatic fat oxidation and energy-expenditure component that mono-agonists structurally cannot replicate [4][5]
The evidence is preclinical (mouse and cell studies)
In some cases, patients in Houston, TX see remarkable results within a week, while others may need additional time and monitoring